Copyright Reports & Markets. All rights reserved.

Global Antacid Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antacid Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Proton Pump Inhibitor
    • 1.3.3 H2 Antagonist
    • 1.3.4 Acid Neutralizers
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antacid Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 OTC Drug
    • 1.4.3 Rx Drug
  • 1.5 Global Antacid Market Size & Forecast
    • 1.5.1 Global Antacid Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Antacid Sales Quantity (2021-2032)
    • 1.5.3 Global Antacid Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Antacid Product and Services
    • 2.1.4 AstraZeneca Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Takeda Pharmaceutical
    • 2.2.1 Takeda Pharmaceutical Details
    • 2.2.2 Takeda Pharmaceutical Major Business
    • 2.2.3 Takeda Pharmaceutical Antacid Product and Services
    • 2.2.4 Takeda Pharmaceutical Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Takeda Pharmaceutical Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Antacid Product and Services
    • 2.3.4 Pfizer Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Reckitt Benckiser
    • 2.4.1 Reckitt Benckiser Details
    • 2.4.2 Reckitt Benckiser Major Business
    • 2.4.3 Reckitt Benckiser Antacid Product and Services
    • 2.4.4 Reckitt Benckiser Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Reckitt Benckiser Recent Developments/Updates
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Antacid Product and Services
    • 2.5.4 Bayer Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bayer Recent Developments/Updates
  • 2.6 Procter＆Gamble
    • 2.6.1 Procter＆Gamble Details
    • 2.6.2 Procter＆Gamble Major Business
    • 2.6.3 Procter＆Gamble Antacid Product and Services
    • 2.6.4 Procter＆Gamble Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Procter＆Gamble Recent Developments/Updates
  • 2.7 GlaxoSmithKline
    • 2.7.1 GlaxoSmithKline Details
    • 2.7.2 GlaxoSmithKline Major Business
    • 2.7.3 GlaxoSmithKline Antacid Product and Services
    • 2.7.4 GlaxoSmithKline Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GlaxoSmithKline Recent Developments/Updates
  • 2.8 Johnson＆Johnson
    • 2.8.1 Johnson＆Johnson Details
    • 2.8.2 Johnson＆Johnson Major Business
    • 2.8.3 Johnson＆Johnson Antacid Product and Services
    • 2.8.4 Johnson＆Johnson Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Johnson＆Johnson Recent Developments/Updates
  • 2.9 CONBA
    • 2.9.1 CONBA Details
    • 2.9.2 CONBA Major Business
    • 2.9.3 CONBA Antacid Product and Services
    • 2.9.4 CONBA Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CONBA Recent Developments/Updates
  • 2.10 Xiuzheng Pharma
    • 2.10.1 Xiuzheng Pharma Details
    • 2.10.2 Xiuzheng Pharma Major Business
    • 2.10.3 Xiuzheng Pharma Antacid Product and Services
    • 2.10.4 Xiuzheng Pharma Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Xiuzheng Pharma Recent Developments/Updates
  • 2.11 Sanofi
    • 2.11.1 Sanofi Details
    • 2.11.2 Sanofi Major Business
    • 2.11.3 Sanofi Antacid Product and Services
    • 2.11.4 Sanofi Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sanofi Recent Developments/Updates
  • 2.12 Bausch Health
    • 2.12.1 Bausch Health Details
    • 2.12.2 Bausch Health Major Business
    • 2.12.3 Bausch Health Antacid Product and Services
    • 2.12.4 Bausch Health Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Bausch Health Recent Developments/Updates
  • 2.13 CR SANJIU
    • 2.13.1 CR SANJIU Details
    • 2.13.2 CR SANJIU Major Business
    • 2.13.3 CR SANJIU Antacid Product and Services
    • 2.13.4 CR SANJIU Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 CR SANJIU Recent Developments/Updates
  • 2.14 Reddy's Laboratories
    • 2.14.1 Reddy's Laboratories Details
    • 2.14.2 Reddy's Laboratories Major Business
    • 2.14.3 Reddy's Laboratories Antacid Product and Services
    • 2.14.4 Reddy's Laboratories Antacid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Reddy's Laboratories Recent Developments/Updates

3 Competitive Environment: Antacid by Manufacturer

  • 3.1 Global Antacid Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Antacid Revenue by Manufacturer (2021-2026)
  • 3.3 Global Antacid Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Antacid by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Antacid Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Antacid Manufacturer Market Share in 2025
  • 3.5 Antacid Market: Overall Company Footprint Analysis
    • 3.5.1 Antacid Market: Region Footprint
    • 3.5.2 Antacid Market: Company Product Type Footprint
    • 3.5.3 Antacid Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antacid Market Size by Region
    • 4.1.1 Global Antacid Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Antacid Consumption Value by Region (2021-2032)
    • 4.1.3 Global Antacid Average Price by Region (2021-2032)
  • 4.2 North America Antacid Consumption Value (2021-2032)
  • 4.3 Europe Antacid Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Antacid Consumption Value (2021-2032)
  • 4.5 South America Antacid Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Antacid Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Antacid Sales Quantity by Type (2021-2032)
  • 5.2 Global Antacid Consumption Value by Type (2021-2032)
  • 5.3 Global Antacid Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Antacid Sales Quantity by Application (2021-2032)
  • 6.2 Global Antacid Consumption Value by Application (2021-2032)
  • 6.3 Global Antacid Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Antacid Sales Quantity by Type (2021-2032)
  • 7.2 North America Antacid Sales Quantity by Application (2021-2032)
  • 7.3 North America Antacid Market Size by Country
    • 7.3.1 North America Antacid Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Antacid Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Antacid Sales Quantity by Type (2021-2032)
  • 8.2 Europe Antacid Sales Quantity by Application (2021-2032)
  • 8.3 Europe Antacid Market Size by Country
    • 8.3.1 Europe Antacid Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Antacid Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antacid Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Antacid Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Antacid Market Size by Region
    • 9.3.1 Asia-Pacific Antacid Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Antacid Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Antacid Sales Quantity by Type (2021-2032)
  • 10.2 South America Antacid Sales Quantity by Application (2021-2032)
  • 10.3 South America Antacid Market Size by Country
    • 10.3.1 South America Antacid Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Antacid Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antacid Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Antacid Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Antacid Market Size by Country
    • 11.3.1 Middle East & Africa Antacid Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Antacid Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Antacid Market Drivers
  • 12.2 Antacid Market Restraints
  • 12.3 Antacid Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antacid and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antacid
  • 13.3 Antacid Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antacid Typical Distributors
  • 14.3 Antacid Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antacid market size was valued at US$ 7036 million in 2025 and is forecast to a readjusted size of US$ 8763 million by 2032 with a CAGR of 3.2% during review period.
    Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they"re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
    Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
    Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
    In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
    This report is a detailed and comprehensive analysis for global Antacid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Antacid market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Antacid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Antacid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2021-2032
    Global Antacid market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Antacid
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Antacid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter＆Gamble, GlaxoSmithKline, Johnson＆Johnson, CONBA, Xiuzheng Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Antacid market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Proton Pump Inhibitor
    H2 Antagonist
    Acid Neutralizers
    Market segment by Application
    OTC Drug
    Rx Drug
    Major players covered
    AstraZeneca
    Takeda Pharmaceutical
    Pfizer
    Reckitt Benckiser
    Bayer
    Procter＆Gamble
    GlaxoSmithKline
    Johnson＆Johnson
    CONBA
    Xiuzheng Pharma
    Sanofi
    Bausch Health
    CR SANJIU
    Reddy's Laboratories
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antacid product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antacid, with price, sales quantity, revenue, and global market share of Antacid from 2021 to 2026.
    Chapter 3, the Antacid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antacid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antacid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antacid.
    Chapter 14 and 15, to describe Antacid sales channel, distributors, customers, research findings and conclusion.

    Buy now